About NTI
Neurotech International Limited (NTI) is a clinical-stage biopharmaceutical development company focused on paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164.
Find out what a historical investment in Neurotech International would be worth today using our NTI stock calculator.
Market Capitalisation
$25.86M
Price-earnings ratio
-2.55
Dividend yield
-
High today
$0.02
Low today
$0.01
Open price
$0.01
52-week high
$0.02
52-week low
$0.01
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NTI
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in NTI on Stake
- Buy NTI from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
NTI related stocks